ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for IFN beta are available for Mouse, Human and Porcine which can be quantified in various samples, including supernatant, plasma, serum.
Invitrogen ELISA kits exist in two formats:...ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for IFN beta are available for Mouse, Human and Porcine which can be quantified in various samples, including supernatant, plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated....ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for IFN beta are available for Mouse, Human and Porcine which can be quantified in various samples, including supernatant, plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated. Uncoated ELISA kits include all the necessary reagents to coat your own plates and run your assay with maximum flexibility. Coated ELISA kits...
ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for IFN beta are available for Mouse, Human and Porcine which can be quantified in various samples, including supernatant, plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated. Uncoated ELISA kits include all the necessary reagents to coat your own plates and run your assay with maximum flexibility. Coated ELISA kits are ready-to-use and quality tested for sensitivity, specificity, precision and lot-to-lot consistency.
IFN beta detection is also available using highly-sensitive ProQuantum Immunoassays. These assays provide a fast, easy workflow with no wash steps, and are detectable with any real-time PCR instrument.
Can't find what you're looking for? Try the ELISA Builder to design your own assay based on target type and experimental needs. We also offer custom ELISA development services.
靶标信息
Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.